Abgent

San Diego, United States Founded: 2001 • Age: 25 yrs Acquired By WuXi AppTec
Primary antibodies are developed for research and drug discovery.

About Abgent

Abgent is a Healthcare company based in San Diego (United States) founded in 2001, and was acquired by WuXi AppTec in October 2011. Primary antibodies are developed for research and drug discovery. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its competitors include GenScript and Epitomics; 2 of its 2 listed competitors have raised funding.

Company details

Abgent was founded in 2001 in San Diego, United States, as a manufacturer focused on antibodies for biological research and drug discovery. A catalog of approximately 20,000 antibody products is maintained. Custom services, including antibody development, peptide synthesis, and protein expression, are provided to support research needs. The company was acquired by WuXi Apptec in October 2011, integrating its operations into broader scientific services.

  • Headquarters San Diego, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website abgent.com
  • Social LinkedIn X
  • Acquired by WuXi AppTec (Oct 2011)
Key Metrics

Investors in Abgent

Abgent has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include WuXi AppTec.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Provider of CRO and CDMO services
2000wuxiapptec.comShanghai, China
Premium access

Investor details for Abgent

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Abgent

2 dated milestones of Abgent across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Abgent is founded.
  2. Exit Acquired by WuXi AppTec.

Competitors of Abgent

Abgent has 2 listed competitors in our database, 2 of them funded. They include GenScript and Epitomics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
epitomics.com2001Burlingame, United States$16.21M
Monoclonal antibody technology and products are developed by Epitomics.
Premium access

Detailed competitors of Abgent

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Abgent

Websites that share an audience with Abgent (abgent.com).

Similar websites

Websites whose visitors overlap most with Abgent. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
abnova.com
100%
30.7K#957,320View details
acris-antibodies.com
acris-antibodies.com
100%
#11,446,421–
epitomics.com
100%
View details
ptglab.com
99%
#137,673View details
imgenex.com
98%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 28 similar websites and full traffic analytics for Abgent

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 28 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Abgent (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Abgent

Abgent was founded in 2001.

Abgent is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Abgent was founded in 2001 in San Diego, United States, as a manufacturer focused on antibodies for biological research and drug discovery. A catalog of approximately 20,000 antibody products is maintained. Custom services, including antibody development, peptide synthesis, and protein expression, are provided to support research needs. The company was acquired by WuXi Apptec in October 2011, integrating its operations into broader scientific services.

Abgent's top competitors include GenScript and Epitomics.

Abgent has 1 investor. Key investors include WuXi AppTec.

Yes. Abgent was acquired by WuXi AppTec in October 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available